Clinical Trials Directory

Trials / Completed

CompletedNCT02404818

Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy

UFPTI 1431 - HL02: Investigating Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Survivors Treated With Either Photon or Proton Radiation

Status
Completed
Phase
Study type
Observational
Enrollment
5 (estimated)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.

Conditions

Interventions

TypeNameDescription
PROCEDURECardiac Magnetic Resonance ImagingA cardiac MRI will be performed.
PROCEDUREEchocardiogramAn echocardiogram will be performed for the following information: M-mode, two-dimensional, Doppler blood flow measurements, and longitudinal strain and strain rate imaging

Timeline

Start date
2015-04-01
Primary completion
2021-04-14
Completion
2021-04-14
First posted
2015-04-01
Last updated
2022-06-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02404818. Inclusion in this directory is not an endorsement.